Literature DB >> 21295615

A non-invasive intranasal inoculation technique using isoflurane anesthesia to infect the brain of mice with rabies virus.

Valérie Rosseels1, Florence Nazé, Stéphane De Craeye, Aurélie Francart, Michael Kalai, Steven Van Gucht.   

Abstract

Methods for intranasal inoculation of viruses are often described poorly and the effects of variations in the technique on the outcome are unknown. Standardization of protocols is key to compare studies and minimize animal use. The clinical and virological outcome of infection with rabies virus (genotypes 1 and 5) upon administration of different inoculum volumes (25, 50 and 100μl) and different anesthetic regimens were examined. Administration of 25μl of virus as a drop on both nostrils under brief superficial isoflurane anesthesia (92μl/dm(3), recovery after 85 ± 1 0s) was the most effective to infect the brain and induced 100% lethal infection 9 days later. Increasing the inoculum volume reduced infectivity significantly, with decreased viral loads in the brain and only 40% mortality. Increasing the depth of isoflurane anesthesia (230μl/dm(3)) improved the infectivity of the large-volume inoculum (90% mortality), probably because of suppression of swallow and sneeze reflexes. Compared to isoflurane anesthesia, xylazine-ketamine anesthesia reduced the infectivity of the inoculum significantly. Thus, administration of a small volume of virus on the nostrils under brief gas anesthesia is a safe and reproducible technique to induce infection of the brain. Since needles are not required, this helps to preserve the integrity of the physical barriers, animal welfare and the manipulator's safety.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21295615     DOI: 10.1016/j.jviromet.2011.01.019

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  12 in total

1.  Inhibition of MALT1 Decreases Neuroinflammation and Pathogenicity of Virulent Rabies Virus in Mice.

Authors:  S Van Gucht; R Beyaert; E Kip; J Staal; H G Tima; L Verstrepen; M Romano; K Lemeire; V Suin; A Hamouda; M Baens; C Libert; M Kalai
Journal:  J Virol       Date:  2018-10-29       Impact factor: 5.103

2.  A novel human anti-VCAM-1 monoclonal antibody ameliorates airway inflammation and remodelling.

Authors:  Jae-Hyun Lee; Jung-Ho Sohn; Su Yeon Ryu; Chein-Soo Hong; Kyung D Moon; Jung-Won Park
Journal:  J Cell Mol Med       Date:  2013-07-16       Impact factor: 5.310

3.  Protective effect of different anti-rabies virus VHH constructs against rabies disease in mice.

Authors:  Sanne Terryn; Aurélie Francart; Sophie Lamoral; Anna Hultberg; Heidi Rommelaere; Angela Wittelsberger; Filip Callewaert; Thomas Stohr; Kris Meerschaert; Ingrid Ottevaere; Catelijne Stortelers; Peter Vanlandschoot; Michael Kalai; Steven Van Gucht
Journal:  PLoS One       Date:  2014-10-27       Impact factor: 3.240

4.  Post-exposure Treatment with Anti-rabies VHH and Vaccine Significantly Improves Protection of Mice from Lethal Rabies Infection.

Authors:  Sanne Terryn; Aurélie Francart; Heidi Rommelaere; Catelijne Stortelers; Steven Van Gucht
Journal:  PLoS Negl Trop Dis       Date:  2016-08-02

5.  Comparative analysis of European bat lyssavirus 1 pathogenicity in the mouse model.

Authors:  Elisa Eggerbauer; Florian Pfaff; Stefan Finke; Dirk Höper; Martin Beer; Thomas C Mettenleiter; Tobias Nolden; Jens-Peter Teifke; Thomas Müller; Conrad M Freuling
Journal:  PLoS Negl Trop Dis       Date:  2017-06-19

6.  Development of in vitro and in vivo rabies virus neutralization assays based on a high-titer pseudovirus system.

Authors:  Jianhui Nie; Xiaohong Wu; Jian Ma; Shouchun Cao; Weijin Huang; Qiang Liu; Xuguang Li; Yuhua Li; Youchun Wang
Journal:  Sci Rep       Date:  2017-02-20       Impact factor: 4.379

7.  Impact of caspase-1/11, -3, -7, or IL-1β/IL-18 deficiency on rabies virus-induced macrophage cell death and onset of disease.

Authors:  E Kip; F Nazé; V Suin; T Vanden Berghe; A Francart; S Lamoral; P Vandenabeele; R Beyaert; S Van Gucht; M Kalai
Journal:  Cell Death Discov       Date:  2017-03-06

8.  MALT1 Controls Attenuated Rabies Virus by Inducing Early Inflammation and T Cell Activation in the Brain.

Authors:  R Beyaert; S Van Gucht; E Kip; J Staal; L Verstrepen; H G Tima; S Terryn; M Romano; K Lemeire; V Suin; A Hamouda; M Kalai
Journal:  J Virol       Date:  2018-03-28       Impact factor: 5.103

9.  A two-step lyssavirus real-time polymerase chain reaction using degenerate primers with superior sensitivity to the fluorescent antigen test.

Authors:  Vanessa Suin; Florence Nazé; Aurélie Francart; Sophie Lamoral; Stéphane De Craeye; Michael Kalai; Steven Van Gucht
Journal:  Biomed Res Int       Date:  2014-04-15       Impact factor: 3.411

10.  Defensins Potentiate a Neutralizing Antibody Response to Enteric Viral Infection.

Authors:  Anshu P Gounder; Nicolle D Myers; Piper M Treuting; Beth A Bromme; Sarah S Wilson; Mayim E Wiens; Wuyuan Lu; André J Ouellette; Katherine R Spindler; William C Parks; Jason G Smith
Journal:  PLoS Pathog       Date:  2016-03-02       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.